TGA rejects Alzheimer’s medication due to safety concerns Advocates say the decision not to register lecanemab is a missed opportunity to begin reversing impacts of Alzheimer’s disease.
‘Practical barriers’ central to low childhood immunisation rates High costs and lack of appointments are the top reasons stopping Australian parents from vaccinating their kids, says groundbreaking new research.
Dementia soon to be Australia’s biggest killer As dementia deaths soar at the same time as heart disease mortality drops, just 237 cases now separate the top two leading causes of death.
National stroke report a call for action With the billion-dollar impact of stroke uncovered, and rates predicted to rise, experts are calling for urgent investment into prevention.
New PBS listing for high-risk CVD patients Experts welcome the listing of Vazkepa, with the treatment aimed at reducing heart attack risks for statin-treated patients with high triglycerides.
In Practice: GP24 early bird registration extended Due to popular demand, the discounted registrations for the Perth conference have been extended to 7 October.
Government defers CDM Medicare item changes The concerns of GPs have been listened to, resulting in the Commonwealth delaying chronic disease management funding changes to 1 July next year.
‘Extremely concerned’: Frustration boils over amid CDM uncertainty The RACGP has demanded the Federal Government delay chronic disease management changes until funding details are clarified.
New dementia data shows proactive care planning is key Just 51% of dementia patients living in the community had a GP CDM attendance, leading one expert to call for more proactive and continuous care.
Do some vaccinations really reduce dementia risk? There is mounting evidence vaccines can reduce the rates of dementia, but one GP says ‘the jury is still out’ on which ones are best.